Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aerosol Science Laboratories (ASL) is a specialized contract research organization (CRO) dedicated to the characterization and development of inhalation and nasal drug products. Based in Carpinteria, California, the company provides comprehensive analytical and testing services, including aerodynamic particle size distribution (APSD), delivered dose uniformity (DDU), and in vitro dissolution for various delivery platforms. ASL supports a broad range of clients in the biotechnology and pharmaceutical sectors, evaluating the performance of nebulizers, dry powder inhalers (DPIs), and metered-dose inhalers (MDIs). Their expertise extends to method development, validation, and stability testing under GMP-compliant standards. By utilizing advanced impaction technologies and lung deposition modeling, the laboratory helps accelerate the transition of respiratory and systemic therapies from preclinical stages to clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aerosol Science Laboratories.